149 related articles for article (PubMed ID: 26834284)
1. Factor V Leiden and Cardiopulmonary Bypass.
Uppal V; Rosin M; Marcoux JA; Olson M; Bezaire J; Dalshaug G
J Extra Corpor Technol; 2015 Dec; 47(4):223-7. PubMed ID: 26834284
[TBL] [Abstract][Full Text] [Related]
2. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
Kanbak M
Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
[TBL] [Abstract][Full Text] [Related]
3. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
4. [A successful perioperative anticoagulation therapy and monitoring of a patient with hereditary plasminogen abnormality undergoing aortic valve replacement].
Miyashita T; Inagawa G; Noumi T; Tachibana K; Kuro M
Masui; 1998 Mar; 47(3):341-5. PubMed ID: 9560548
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
6. Factor XII Deficiency and Cardiopulmonary Bypass.
Uppal V; Rosin M
J Extra Corpor Technol; 2014 Sep; 46(3):254-7. PubMed ID: 26357792
[TBL] [Abstract][Full Text] [Related]
7. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
8. Heparin sensitivity test for patients requiring cardiopulmonary bypass.
DeBois WJ; Liu J; Elmer B; Ebrahimi H; Voevidko L; Lee LY; Krieger KH; Isom WW; Girardi LN
J Extra Corpor Technol; 2006 Dec; 38(4):307-9. PubMed ID: 17312901
[TBL] [Abstract][Full Text] [Related]
9. Perioperative anticoagulation management during aortic valve replacement complicated by antiphospholipid syndrome.
Nakajima T; Enomoto Y; Ishigaki M; Hasegawa Y; Tokunaga C; Hiramatsu Y; Sakamoto H
J Card Surg; 2017 Oct; 32(10):633-635. PubMed ID: 28944492
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.
Owings JT; Pollock ME; Gosselin RC; Ireland K; Jahr JS; Larkin EC
Arch Surg; 2000 Sep; 135(9):1042-7. PubMed ID: 10982508
[TBL] [Abstract][Full Text] [Related]
11. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
12. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
13. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
[TBL] [Abstract][Full Text] [Related]
14. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
15. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
[TBL] [Abstract][Full Text] [Related]
16. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test.
Wallock M; Jeske WP; Bakhos M; Walenga JM
Perfusion; 2001 Mar; 16(2):147-53. PubMed ID: 11334198
[TBL] [Abstract][Full Text] [Related]
18. Use of aprotinin during cardiopulmonary bypass in a patient with protein C deficiency.
Sievert A; McCall M; Blackwell M; Bradley S
J Extra Corpor Technol; 2003 Mar; 35(1):39-43. PubMed ID: 12680495
[TBL] [Abstract][Full Text] [Related]
19. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
[TBL] [Abstract][Full Text] [Related]
20. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
Levin AI; Heine AM; Coetzee JF; Coetzee A
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
